本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

康乃德生物醫藥

2.00
-0.0200-0.99%
盤後2.000.00000.00%16:20 EDT
成交量:24.06萬
成交額:47.81萬
市值:1.11億
市盈率:-6.42
高:2.19
開:2.01
低:1.83
收:2.02
資料載入中...
2025/07/22

重要事件披露

Form 8-K - Current report
2025/07/21

重要事件披露

Form 8-K - Current report
2025/07/17

重要事件披露

Form 8-K - Current report
2025/07/09

重要事件披露

Form 8-K - Current report
2025/06/24

SEC問詢函

Form CORRESP - Correspondence
2025/06/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/10

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/05/15

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/15

重要事件披露

Form 8-K - Current report
2025/05/14

重要事件披露

Form 8-K - Current report
2025/05/13

重要事件披露

Form 8-K - Current report
2025/04/01

重要事件披露

Form 8-K - Current report
2025/03/31

重要事件披露

Form 8-K - Current report
2025/03/31

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/07/01

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/04/16

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/27

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/27

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/13

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]